CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-31 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $135.42 | $1.3M | 333,943 |
| 2026-07-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −365 | $514.82 | $188K | 333,578 |
| 2026-07-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −857 | $515.84 | $442K | 332,721 |
| 2026-07-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,133 | $516.94 | $586K | 331,588 |
| 2026-07-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,215 | $518.00 | $629K | 330,373 |
| 2026-07-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,266 | $519.06 | $657K | 329,107 |
| 2026-07-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,627 | $520.12 | $1.4M | 326,480 |
| 2026-07-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,517 | $520.80 | $790K | 324,963 |
| 2026-07-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −282 | $521.52 | $147K | 324,681 |
| 2026-07-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −238 | $522.88 | $124K | 324,443 |
| 2026-07-31 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 227,410 | ||
| 2026-07-30 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $135.42 | $1.3M | 333,943 |
| 2026-07-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −644 | $523.04 | $337K | 333,299 |
| 2026-07-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,486 | $523.87 | $778K | 331,813 |
| 2026-07-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −4,846 | $524.88 | $2.5M | 326,967 |
| 2026-07-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,084 | $525.80 | $1.1M | 324,883 |
| 2026-07-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $526.92 | $211K | 324,483 |
| 2026-07-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $528.96 | $21K | 324,443 |
| 2026-07-30 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 236,910 | ||
| 2026-07-29 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $135.42 | $1.3M | 333,943 |
Page 59 of 121 · 2,404 trades